Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]-, hydrochloride (1:2), 98%, 1g

N-methyl-N-[(3R)-piperidin-3-yl]acetamide hydrochloride, 95.0%, 100mg

Pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one, 95.0%, 5g

Succinic acid, min. 99%, 1 kg, plastic packaging.

Syringe filters Minisart® NY Non-sterile, 0,2 µm, 15 mm, 50 Piece(s)

Bis(4-fluorophenyl)iodonium triflate, 98%, 5g

5,6,11,12-Tetraphenylnaphthacene>98.0%(HPLC)1g

(2S,2'S,3S,3'S)-4,4'-Di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97%, 250mg

(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE, 95%, 5g

(3-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid, 96%, 5g

Ethyl 4-bromo-2-chloro-5-fluorobenzoate, 97.0%, 500mg

DIMETHYL 2-(5-FLUORO-2-NITROPHENYL)MALONATE, 95.0%, 250mg

(1S,2S)-2-(4-CHLOROPHENYL)CYCLOPROPANE-1-CARBOXYLIC ACID, 95.0%, 100mg